Temporal changes in the risk of six-month post-COVID symptoms: a national population-based cohort study - Top-Institutions - MDSpire

Temporal changes in the risk of six-month post-COVID symptoms: a national population-based cohort study

  • By

  • Anne Pastorello

  • Laurence Meyer

  • Joël Coste

  • Camille Davisse-Paturet

  • Xavier de Lamballerie

  • Maria Melchior

  • Sophie Novelli

  • Delphine Rahib

  • Nathalie Bajos

  • Cécile Vuillermoz

  • Jeanna-Eve Franck

  • Carmelite Manto

  • Alexandra Rouquette

  • Josiane Warszawski

  • EpiCov study group

  • July 3, 2024

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Public Health

  • #2

    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Infectious Diseases
    • Clinical Research

  • #3

    University of Oxford
    University of Oxford

    Oxford, United Kingdom

    Key Differentiators

    • Epidemiology
    • Infectious Diseases
    • Public Health

  • #4

    Institut Pasteur
    Institut Pasteur

    Paris, France

    Key Differentiators

    • Virology
    • Infectious Diseases
    • Epidemiology

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Epidemiology
    • Infectious Diseases
    • Public Health

Original Source(s)

Temporal changes in the risk of six-month post-COVID symptoms: a national population-based cohort study

  • by Anne Pastorello, Laurence Meyer, Joël Coste, Camille Davisse-Paturet, Xavier de Lamballerie, Maria Melchior, Sophie Novelli, Delphine Rahib, Nathalie Bajos, Cécile Vuillermoz, Jeanna-Eve Franck, Carmelite Manto, Alexandra Rouquette, Josiane Warszawski, EpiCov study group

  • July 3, 2024

Related Content

COVID-19 webinar: COVID-19 and the rapid transition to a virtual practice

John D. Halamka, M.D., M.S., president of the Mayo Clinic Platform, and other Mayo Clinic experts discuss advanced telemedicine and the role this alternative care setting will play amid an evolving health care landscape. (Credit is available.)

  • September 3, 2020

  • 1 min
The impact of the COVID-19 pandemic on renal cancer care

Lifting the Stigma of HPV-Associated Oropharyngeal Cancer: Insights from Dr. Tom Thomas at Morristown Medical Center

Although a stigma has persisted surrounding human papillomavirus (HPV)–associated head and neck cancers, a lot of progress has been made through education efforts within the head and neck surgical oncology community.

  • by

  • April 3, 2024

  • 9 min